The US Food and Drug Administration on Wednesday approved a new obesity pill called Foundayo. Taken once daily, the pill is made by pharmaceutical company Eli Lilly, which also manufactures the ...

Eli Lilly LLY2.39%increase; green up pointing triangle has agreed to buy clinical-stage company Centessa Pharmaceuticals CNTA-0.05%decrease; red down pointing triangle for an initial payment of about ...

The Horror Section‘s Ice Cream Man from Eli Roth will hit theaters on Aug. 7 via Iconic Events Releasing in what will be a 2,000 theater break. Ice Cream Man follows an idyllic summer town descending ...

“Nas is one of the most influential storytellers and cultural voices of all time and we bonded instantly over our mutual love of horror,” said Roth in a statement. “We are thrilled to partner with ...

Eli Lilly has partnered with AI biotech Insilico Medicine for exclusive global rights to develop and commercialise medicines designed entirely by artificial intelligence. Eli Lilly and Insilico ...

Eli Lilly (LLY) is down to the $937 area as investors await an April FDA decision on its oral obesity pill, orforglipron. Moreover, shares of Eli Lilly rival Novo Nordisk (NVO) are down 25% year to ...

Eli Lilly (LLY) has issued a public warning about potential safety risks associated with compounded tirzepatide mixed with vitamin B12. Lilly tested compounded products and found “significant levels ...

SHANGHAI, March 11 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to invest $3 billion in China over the next decade, which will help build production capacity for its experimental ‌type-2 ...

A pharmaceutical hub is rapidly developing in Central Virginia, and Goochland County is poised to reap the benefits thanks to a $5 billion investment by Eli Lilly & Co. The manufacturing plant coming ...

Vanderbilt's Eli Stowers is one of the best tight end prospects in the 2026 NFL Draft. An impressive blend of athleticism and versatility makes Stowers a mismatch weapon. Stowers should be a Day 2 ...

Eli Lilly's new GLP-1 pill surged ahead of competitor Novo Nordisk's in a head-to-head trial. Patients on Lilly's pill had better blood sugar levels, lost more weight, and improved heart health. The ...

It’s a good day to be the pharmaceutical giant Eli Lilly. Right now, Eli Lilly appears to be the leader in the GLP-1 race amid multiple difficult headwinds for Novo Nordisk. As of this writing, Novo ...